Cargando…

Blood-based biomarkers for immune-based therapy in advanced HCC: Promising but a long way to go

The introduction of immune checkpoint inhibitors (ICIs) represents a key shift in the management strategy for patients with hepatocellular carcinoma (HCC). However, there is a paucity of predictive biomarkers that facilitate the identification of patients that would respond to ICI therapy. Although...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sung, Pil Soo, Lee, Isaac Kise, Roh, Pu Reun, Kang, Min Woo, Ahn, Jaegyoon, Yoon, Seung Kew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659956/ https://www.ncbi.nlm.nih.gov/pubmed/36387149 http://dx.doi.org/10.3389/fonc.2022.1028728

Ejemplares similares

Intrahepatic inflammatory IgA(+)PD-L1(high) monocytes in hepatocellular carcinoma development and immunotherapy
por: Sung, Pil Soo, et al.
Publicado: (2022)

HCC biomarkers – state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice
por: Schlosser, Sophie, et al.
Publicado: (2022)

Death-Associated Protein 6 (Daxx) Alleviates Liver Fibrosis by Modulating Smad2 Acetylation
por: Kim, Sung-Min, et al.
Publicado: (2021)

SLC1A4: A Powerful Prognostic Marker and Promising Therapeutic Target for HCC
por: Peng, Xiaozhen, et al.
Publicado: (2021)

Kill and Clearance in HCC: An Approach Based on NK Cells and Macrophages
por: Mehrabi, Maryam, et al.
Publicado: (2021)

Diffusion-Weighted Magnetic Resonance Imaging in Hepatocellular Carcinoma as a Predictor of a Response to Cisplatin-Based Hepatic Arterial Infusion Chemotherapy
por: Sung, Pil Soo, et al.
Publicado: (2020)

Splenic Volume, an Easy-To-Use Predictor of HCC Late Recurrence for HCC Patients After Hepatectomy
por: Fang, Tongdi, et al.
Publicado: (2022)

Factors associated with the survival outcomes of patients with untreated hepatocellular carcinoma: An analysis of nationwide data
por: Kwon, Min Jung, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors in the Treatment of HCC
por: Donisi, Clelia, et al.
Publicado: (2021)

Study on the changes of CT texture parameters before and after HCC treatment in the efficacy evaluation and survival predication of patients with HCC
por: Zhou, Wei, et al.
Publicado: (2022)

Validating RRP12 Expression and Its Prognostic Significance in HCC Based on Data Mining and Bioinformatics Methods
por: Wei, Chao, et al.
Publicado: (2022)

Prediction of early recurrence of HCC after hepatectomy by contrast-enhanced ultrasound-based deep learning radiomics
por: Zhang, Hui, et al.
Publicado: (2022)

DOACs in patients with brain cancers: promising but still a long way to go
por: Giustozzi, Michela, et al.
Publicado: (2022)

A Network-Based Classification Model for Deriving Novel Drug-Disease Associations and Assessing Their Molecular Actions
por: Oh, Min, et al.
Publicado: (2014)

A novel HCC prognosis predictor PDSS1 affects the cell cycle through the STAT3 signaling pathway in HCC
por: Rao, Zuqin, et al.
Publicado: (2022)

Higher Number of Tumor-Infiltrating PD-L1+ Cells Is Related to Better Response to Multikinase Inhibitors in Hepatocellular Carcinoma
por: Han, Ji Won, et al.
Publicado: (2023)

US-Based Deep Learning Model for Differentiating Hepatocellular Carcinoma (HCC) From Other Malignancy in Cirrhotic Patients
por: Zhou, Hang, et al.
Publicado: (2021)

Can Risk Stratification Based on Ultrasound Elastography of Background Liver Assist CEUS LI-RADS in the Diagnosis of HCC?
por: Li, Jiawu, et al.
Publicado: (2021)

Exosomal miR-125b Exerts Anti-Metastatic Properties and Predicts Early Metastasis of Hepatocellular Carcinoma
por: Kim, Hye Seon, et al.
Publicado: (2021)

Biomarker for recurrent immunoglobulin A nephropathy in kidney allografts: promising but still a long way to go
por: Chung, Byung Ha
Publicado: (2021)

Upregulation of Serum Sphingosine (d18:1)-1-P Potentially Contributes to Distinguish HCC Including AFP-Negative HCC From Cirrhosis
por: Jiang, Yingying, et al.
Publicado: (2020)

Preoperative Gadoxetic Acid-Enhanced MRI Based Nomogram Improves Prediction of Early HCC Recurrence After Ablation Therapy
por: Hu, Chengguang, et al.
Publicado: (2021)

Virtual Reality Simulation-Based Training: The Way to Go!
por: Küttner-Magalhães, Ricardo, et al.
Publicado: (2022)

Biomarkers in cancer: is ‘omices’ the way to go
por: Buhmeida, Abdelbaset, et al.
Publicado: (2011)

A Nomogram Based on Preoperative Inflammatory Indices and ICG-R15 for Prediction of Liver Failure After Hepatectomy in HCC Patients
por: Fang, Tongdi, et al.
Publicado: (2021)

Prognostic value of combined inflammatory and nutritional biomarkers in HCC within the Milan criteria after hepatectomy
por: Feng, Hanxin, et al.
Publicado: (2022)

Cabozantinib for HCC Treatment, From Clinical Back to Experimental Models
por: Deng, Shanshan, et al.
Publicado: (2021)

Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC)
por: Zhao, Pin, et al.
Publicado: (2021)

Evaluation of D-TACE combined with endovascular brachytherapy for HCC with MPVTT
por: Huang, Wei, et al.
Publicado: (2022)

Hsa-miR-4277 Decelerates the Metabolism or Clearance of Sorafenib in HCC Cells and Enhances the Sensitivity of HCC Cells to Sorafenib by Targeting cyp3a4
por: He, Xi, et al.
Publicado: (2021)

Going separate ways
por: Leslie, Mitch
Publicado: (2001)

Way to go, RNA
por: Belasco, Joel G.
Publicado: (2015)

Tumor-Educated Platelets as a Promising Biomarker for Blood-Based Detection of Renal Cell Carcinoma
por: Xiao, Ruotao, et al.
Publicado: (2022)

Roles of lncRNAs Mediating Wnt/β-Catenin Signaling in HCC
por: Xu, Yating, et al.
Publicado: (2022)

Targeting mitochondrial quality control of T cells: Regulating the immune response in HCC
por: Xia, Yixue, et al.
Publicado: (2022)

A key driver to promote HCC: Cellular crosstalk in tumor microenvironment
por: Liu, Pengyue, et al.
Publicado: (2023)

A Multi-Sample Based Method for Identifying Common CNVs in Normal Human Genomic Structure Using High-Resolution aCGH Data
por: Park, Chihyun, et al.
Publicado: (2011)

Overexpressed Proteins in HCC Cell-Derived Exosomes, CCT8, and Cofilin-1 Are Potential Biomarkers for Patients with HCC
por: Cho, Hyo Jung, et al.
Publicado: (2021)

Real-World Outcomes of Nivolumab in Patients With Unresectable Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus Infection
por: Sung, Pil Soo, et al.
Publicado: (2020)

Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC
por: Abudoureyimu, Mubalake, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o6srilj0gi6d9oj74j1jtuu0ol